Matthew Paul Kowalsky - Apr 29, 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role: Chief Legal Officer
Signature: /s/ Matthew Paul Kowalsky
Stock symbol: ENTA
Transactions as of: Apr 29, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/1/2024, 04:27 PM
Previous filing: Aug 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENTA	Stock Option (right to buy)	+Grant/Award	$0	+150,000		$0.00	150,000	Apr 29, 2024	Common Stock	150,000	$13.25	Direct	F1

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of such option will become exercisable on April 29, 2025 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).

Content

Twenty-five percent (25%) of such option will become exercisable on April 29, 2025 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).